Jeffrey B. Mirviss - 24 Feb 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
24 Feb 2025
Net transactions value
-$766,921
Form type
4
Filing time
25 Feb 2025, 16:41:43 UTC
Previous filing
19 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Sale $487,369 -4,675 -14% $104.25 28,454 24 Feb 2025 Direct F1
transaction BSX Common Stock Sale $279,552 -2,688 -9.4% $104.00 25,766 25 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 21, 2024.